Shreehas Tambe appointed CEO & MD of Biocon Limited from April 1, 2026, to lead integrated biosimilars and generics business globally.
Read More
Think | Create | Scale
Most Commented News
Shreehas Tambe appointed CEO & MD of Biocon Limited from April 1, 2026, to lead integrated biosimilars and generics business globally.
Read More